Ph.D. candidate Roshan Chikarmane identifies key drivers of rising drug prices and introduces corresponding interventions that are being undertaken by business leaders to shift industry trends toward more affordable health care.
On Sept. 23, 2019, Sam Hopkins, Commercialization Academy manager, and Jessica Miciak, Ph.D. candidate in cellular and molecular medicine at The Johns Hopkins University, provided an overview of the Commercialization Academy — a learning opportunity for graduate students and postdoctoral fellows interested in the commercial assessment and marketing of Johns Hopkins technologies.
The explosion of digital health interventions has prompted significant investment. As the industry has begun to mature, substantial effort has been made to create an… Read More »Insights from the Rock Health Enterprise Insights Series
This past April, the Johns Hopkins Graduate Consulting Club (JHGCC) held its annual Biotech and Healthcare Case Competition. For the past five years, this event… Read More »Hopkins-Engineered HPV Vaccine Wins Big in Recent Business Competitions